* Shockwave Medical Inc SWAV.OQ SWAV.O is expected
to show a
rise in quarterly revenue when it reports results on May 9.
* The Santa Clara California-based company is expected to
report
a 170.9% increase in revenue to $86.407 million from $31.9
million a year ago, according to the mean estimate from 7
analysts, based on Refinitiv data.
* Refinitiv's mean analyst estimate for Shockwave Medical
Inc is
for earnings of 18 cents per share. For the same quarter last
year, the company reported a loss of 68 cents per share.
* The current average analyst rating on the shares is "buy"
and
the breakdown of recommendations is 6 "strong buy" or "buy," 2
"hold" and no "sell" or "strong sell."
* The mean earnings estimate of analysts was unchanged in
the last
three months.
* Wall Street's median 12-month price target for Shockwave
Medical
Inc is $235, above its last closing price of $137.30.
* Previous quarterly performance (using preferred earnings
measure
in US dollars).
QUARTER STARMINESM REFINITIV ACTUAL BEAT, SURPRI
ENDING ARTESTIMAT IBES MET, SE %
E® ESTIMATE MISSED
Dec. 31 2021 0.11 0.09 0.34 Beat 300
Sep. 30 2021 -0.05 -0.06 0.05 Beat 187.5
Jun. 30 2021 -0.37 -0.40 -0.01 Beat 97.5
Mar. 31 2021 -0.46 -0.45 -0.68 Missed -52.2
Dec. -0.42 -0.42 -0.46 Missed -8.7
31 2020
Sep. 30 2020 -0.56 -0.55 -0.38 Beat 31.3
Jun. 30 2020 -0.63 -0.62 -0.56 Beat 9.9
Mar. 31 2020 -0.50 -0.49 -0.59 Missed -20
This summary was machine generated May 7 at 02:04 GMT. All
figures in US dollars unless otherwise stated